Search for: "Johnson v. Bristol-Myers Squibb Co et al"
Results 1 - 9
of 9
Sorted by Relevance
|
Sort by Date
20 Jun 2017, 1:15 pm
” Bristol-Myers Squibb Co. v. [read post]
26 Jun 2015, 11:30 am
Johnson & Johnson et al., No. [read post]
9 Apr 2009, 7:52 am
(Part I - Patent Circle) (Part II – Patent Circle) Indian biogenerics on an upswing – US Promoting Innovation and Access to Life-Saving Medicine Act (Patent Baristas) US: Anti-reverse payment legislation Protecting Consumer Access to Generic Drugs Act of 2009 introduced in the House (Patent Docs) US: CAFC clarifies obviousness standard in context of cDNA cloning invention: In re Kubin (Holman's Biotech IP Blog) (Patent Docs) (Hal Wegner) (Philip Brooks' Patent… [read post]
27 Feb 2009, 7:00 am
(BLOG@IP::JUR) Changes to EPO fee structure, 1 April 2009 (BLOG@IP::JUR) (Patent Baristas) Changes of patent culture (BLOG@IP::JUR) MARQUES 3rd annual review of community design case law (Managing Intellectual Property) PDO amendment – Chabichou du Poitou (Class 46) France French trade marks database opens publicly on 3 April 2009 (Class 46) Union pour un Mouvement Populaire to compensate MGMT for use of song ‘Kids’ at party rallies without seeking permission… [read post]
9 Aug 2012, 5:00 am
Bristol-Myers Squibb (?) [read post]
2 Mar 2012, 6:52 am
Bristol-Myers Squibb (?) [read post]
28 Apr 2008, 11:00 am
: (Patent Docs), US: Supreme Court declines to hear final Nucleonics’ appeal in gene-silencing patent dispute with Benitec Australia: (IP Law360), (Therapeutics Daily), US: 505(b)(2) drug approvals rock - Interaction of patents and exclusivity of drugs approved by FDA under section 505(b)(2): (Patent Baristas), US: StemCells’ patents survive reexam – StemCells and Neuralstem differ on extent of changes: (Patent Docs), US: StemCells announces issuance of… [read post]
2 May 2008, 7:00 am
: Lupin v Abbott Labs: (FDA Law Blog), Plavix (Clopidogrel) – US: Apotex sues FDA to recover 180-day exclusivity on generic Plavix: (Orange Book Blog), Plavix (Clopidogrel) – US: Former Bristol-Myers Squibb executive charged over lying about Plavix deal struck with rival Apotex: (Managing Intellectual Property), Risperdal (Resperidone) – US: Apotex files motion to intervene in relisting of Risperdal patent case; Teva… [read post]
12 Jan 2017, 7:01 am
Amgen Inc., et al., 15-1039 and Amgen Inc. v. [read post]
